Get the latest Climara shortage update for 2026. Learn about current availability, which strengths are affected, and what patients can do right now.
If you rely on Climara to manage menopause symptoms, you've likely noticed that filling your prescription has become more difficult. In this article, we provide the latest information about the Climara supply situation in 2026, explain which strengths are most affected, and share practical steps you can take to keep your treatment on track.
As of February 2026, Climara (estradiol transdermal system) continues to experience intermittent supply challenges at pharmacies across the United States. While Climara is not consistently listed on the FDA's official Drug Shortage Database, many patients and pharmacists report difficulty obtaining the product — especially in certain strengths.
The supply issues are not unique to Climara. Several estradiol transdermal products have faced availability challenges since 2022, driven by manufacturing constraints, increased demand for hormone replacement therapy, and limited production capacity for transdermal patches.
Climara comes in six strengths:
Reports suggest that the 0.05 mg/day and 0.075 mg/day strengths — two of the most commonly prescribed doses — have been among the hardest to find. However, availability can vary significantly by region and pharmacy.
Several factors contribute to the ongoing supply challenges:
Transdermal patches are more complex to manufacture than tablets or capsules. Climara is manufactured by 3M Drug Delivery Systems for Bayer HealthCare Pharmaceuticals. The specialized equipment and materials needed mean there are fewer facilities capable of producing these patches.
Demand for estradiol patches has grown significantly as more women seek hormone replacement therapy for menopause. Updated guidelines and greater awareness of HRT benefits have contributed to a surge in prescriptions that manufacturers have struggled to keep up with.
The specialized adhesives, films, and active pharmaceutical ingredients used in transdermal patches have been subject to supply chain disruptions affecting the entire pharmaceutical industry.
Going without your estradiol patch can cause menopause symptoms to return quickly. Hot flashes, night sweats, mood changes, and vaginal dryness can reappear within days of missing a dose. For patients using Climara for osteoporosis prevention, interruptions in therapy can reduce the bone-protective benefits.
Important: Do not stop your hormone therapy abruptly without consulting your doctor. If you can't find Climara, reach out to your healthcare provider to discuss alternatives.
Use MedFinder to check which pharmacies near you currently have Climara in stock. This is the fastest way to find available supply without calling multiple pharmacies.
Generic versions of estradiol transdermal patches are available from multiple manufacturers. They contain the same active ingredient as Climara and cost significantly less — typically $25 to $60 for a box of 4 weekly patches versus $130 to $200 for brand-name Climara.
If no estradiol patches are available, your doctor may recommend switching to:
Learn more in our guide to Climara alternatives.
Independent pharmacies, mail-order pharmacies, and specialty hormone pharmacies may have different supply chains than large retail chains. Our guide on how to find Climara in stock has detailed tips on where to look.
Don't wait until you're on your last patch to refill. Most insurance plans allow refills 7 days before your supply runs out. Filing early gives your pharmacy time to order more if they're low on stock.
It's difficult to predict exactly when Climara supply will fully stabilize. Manufacturing capacity for transdermal patches takes time to expand, and demand continues to grow. However, the availability of generic estradiol patches from multiple manufacturers means that the overall supply of estradiol transdermal products is improving, even if brand-name Climara remains inconsistent.
We will continue to update this page as new information becomes available.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
